A report on New Psychoactive Substances (NPS)

While prevalence levels of NPS use remain low in the general European population, there are important concerns with more problematic forms of use and harms. This short report provides an overview of the current situation in terms of NPS use and harms across Europe and reviews the available health- and drug-related interventions in that area. Report available from EMCDDA

 © DLR - DATF, 2016   C/O Southside Partnership, Main st., Blackrock, Co. Dublin Tel: 01-7060125 / 087-6494922  dlralcoholanddrugs@gmail.com